Article Details
Retrieved on: 2021-10-04 09:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Though efficacy of ZyCoV-D was 67% compared to mRNA vaccine and others which is about 90%, there have not been late stage trials which Zydus Cadila has ...
Article found on: www.financialexpress.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here